Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02215655 · ClinicalTrials.gov registry record · NA
Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT02215655 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 150 participants.
The verdict
NCT02215655, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
Hyperphosphatemia in end-stage renal disease (ESRD) patients is a non-traditional risk factor for all-cause and cardiovascular mortality. Non-adherence to phosphate binders is as high as 74% in ESRD patients and has been shown to be most related to psychosocial factors including attitudes. There is limited data on the influence of attitudes and perceived autonomy support on phosphate binder adherence and these two psychosocial constructs can be positively influenced through the use of motivational interviewing skills to increase autonomous motivation. Furthermore, racial disparities are known to exist in ESRD however and there are still gaps, which exist in understanding the determinants of disparities in adherence in vulnerable patients with ESRD. In this study, the investigators seek to determine the impact of motivational interviewing on phosphate binder adherence in diverse ESRD patients. The investigators will ask all the subjects to fill out surveys mainly regarding their attitudes; perceived providers' autonomy support and phosphate binder adherence. The investigators will administer motivational counseling to subjects in the intervention arm of the study, at baseline and 1 month after recruitment. The investigators will ask all the subjects to fill out the same surveys 2 months after recruitment and the investigators will compare subjects who underwent motivational interviewing to those who did not.
Interventions
- BEHAVIORAL Motivational interviewing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02215655
The ClinicalTrials.gov registry entry for NCT02215655 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Motivational interviewing is the first listed.
NCT02215655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02215655 about?
NCT02215655 is a clinical study titled "Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence". Hyperphosphatemia in end-stage renal disease (ESRD) patients is a non-traditional risk factor for all-cause and cardiovascular mortality. Non-adherence to phosphate binders is as high as 74% in ESRD patients and has been shown to be most related to psychosocial factors including attitudes. There is ...
What is the current status of trial NCT02215655?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2014-09. Estimated completion is 2015-05.
What interventions are being tested in trial NCT02215655?
The interventions under investigation include: Motivational interviewing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02215655?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.